Found: 75
Select item for more details and to access through your institution.
Wavelet phase coherence of ictal scalp EEG-extracted muscle activity (SMA) as a biomarker for sudden unexpected death in epilepsy (SUDEP).
- Published in:
- PLoS ONE, 2024, v. 19, n. 8, p. 1, doi. 10.1371/journal.pone.0298943
- By:
- Publication type:
- Article
Radiographic and metabolic evolution of prostate cancer lung metastasis detected by prostate-specific membrane antigen and fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
- Published in:
- World Journal of Nuclear Medicine, 2020, v. 19, n. 4, p. 421, doi. 10.4103/wjnm.WJNM_17_20
- By:
- Publication type:
- Article
Fluorodeoxyglucose Uptake in Lipomatous Hypertrophy of the Interatrial Septum is Not Likely Related to Brown Adipose Tissue.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Nuclear Medicine in the First Year of Life.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 6, p. 905, doi. 10.2967/jnumed.110.084202
- By:
- Publication type:
- Article
Evaluation of <sup>18</sup>F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor Consortium.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 2, p. 188, doi. 10.2967/jnumed.110.081463
- By:
- Publication type:
- Article
CCCDTD5: Clinical role of neuroimaging and liquid biomarkers in patients with cognitive impairment.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020, v. 6, n. 1, p. 1, doi. 10.1002/trc2.12098
- By:
- Publication type:
- Article
Clinical and Technical Considerations for Brain PET Imaging for Dementia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Case - Prostate-specific antigen bounce: A pitfall in prostate-specific membrane antigen positron emission tomography/computed tomography interpretation.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 11, p. E620, doi. 10.5489/cuaj.7257
- By:
- Publication type:
- Article
Case series--<sup>18</sup>F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 7, p. E376, doi. 10.5489/cuaj.6984
- By:
- Publication type:
- Article
Canadian Urological Association best practice report: Prostatespecific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 6, p. 162, doi. 10.5489/cuaj.7268
- By:
- Publication type:
- Article
Bone scan use in the management of metastatic castration-resistant prostate cancer: Survey of practice patterns among Canadian radiation oncologists, medical oncologists, and urologists.
- Published in:
- Canadian Urological Association Journal, 2020, v. 14, n. 11, p. E601, doi. 10.5489/cuaj.6320
- By:
- Publication type:
- Article
A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical based therapy.
- Published in:
- Canadian Urological Association Journal, 2020, v. 14, n. 4, p. 130, doi. 10.5489/cuaj.6506
- By:
- Publication type:
- Article
Interreader and Intrareader Reproducibility of <sup>18</sup>F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267306
- By:
- Publication type:
- Article
MANAGEMENT OF DIFFERENTIATED THYROID CANCER: THE STANDARD OF CARE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262402
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate- Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
MANAGEMENT OF DIFFERENTIATED THYROID CANCER: THE STANDARD OF CARE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262402
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted 18F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
MANAGEMENT OF DIFFERENTIATED THYROID CANCER: THE STANDARD OF CARE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262402
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on ProstateSpecific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.251512
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate- Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 33, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.259069
- By:
- Publication type:
- Article
Machine Learning in Nuclear Medicine: Part 2-Neural Networks and Clinical Aspects.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.231837
- By:
- Publication type:
- Article
Machine Learning in Nuclear Medicine: Part 2-Neural Networks and Clinical Aspects.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.231837
- By:
- Publication type:
- Article
Machine Learning in Nuclear Medicine: Part 2-Neural Networks and Clinical Aspects.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.231837
- By:
- Publication type:
- Article
Part 1: Introduction to Machine Learning in the Nuclear Medicine Context.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.223495
- By:
- Publication type:
- Article
Invited Perspective on an International Survey of PET/CT Clinical Reporting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.223073
- By:
- Publication type:
- Article
Fifth Anniversary of SNMMI Professional Relations Fellowship.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 20N
- By:
- Publication type:
- Article
Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 677, doi. 10.2967/jnumed.118.219998
- By:
- Publication type:
- Article
An International Survey of PET/CT Clinical Reporting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 4, p. 478, doi. 10.2967/jnumed.118.223073
- By:
- Publication type:
- Article
Machine Learning in Nuclear Medicine: Part 1—Introduction.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 4, p. 451, doi. 10.2967/jnumed.118.223495
- By:
- Publication type:
- Article
Harmonization of U.S., European Union, and Canadian First-in-Human Regulatory Requirements for Radiopharmaceuticals: Is This Possible?
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 158, doi. 10.2967/jnumed.118.209460
- By:
- Publication type:
- Article
Appropriate Use Criteria for <sup>18</sup>F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 12, p. 2026, doi. 10.2967/jnumed.117.197988
- By:
- Publication type:
- Article
Correlation of <sup>18</sup>F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 8, p. 1264, doi. 10.2967/jnumed.116.185389
- By:
- Publication type:
- Article
SNMMI Comment on the 2016 Society of Surgical Oncology “Choosing Wisely” Recommendation on the Use of PET/CT in Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 11, doi. 10.2967/jnumed.116.182584
- By:
- Publication type:
- Article
Response Assessment Criteria and Their Applications in Lymphoma: Part 2.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 13, doi. 10.2967/jnumed.116.184242
- By:
- Publication type:
- Article
Response Assessment Criteria and Their Applications in Lymphoma: Part 1.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 6, p. 928, doi. 10.2967/jnumed.115.166280
- By:
- Publication type:
- Article
Proceedings of the Second NCI--SNMMI Workshop on Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 7, p. 1119, doi. 10.2967/jnumed.115.159038
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET and MR Imaging Associations Across a Spectrum of Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 9, p. 1473, doi. 10.2967/jnumed.114.139626
- By:
- Publication type:
- Article
Exploratory Evaluation of MR Permeability with <sup>18</sup>F-FDG PET Mapping in Pediatric Brain Tumors: A Report from the Pediatric Brain Tumor Consortium.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 8, p. 1237, doi. 10.2967/jnumed.112.115782
- By:
- Publication type:
- Article
Reporting Guidance for Oncologic <sup>18</sup>F-FDG PET/CT Imaging.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 5, p. 756, doi. 10.2967/jnumed.112.112177
- By:
- Publication type:
- Article
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
- Published in:
- Abdominal Imaging, 2013, v. 38, n. 4, p. 728, doi. 10.1007/s00261-012-9958-3
- By:
- Publication type:
- Article
Detecting lumbar lesions in <sup>99m</sup>Tc‐MDP SPECT by deep learning: Comparison with physicians.
- Published in:
- Medical Physics, 2021, v. 48, n. 8, p. 4249, doi. 10.1002/mp.15033
- By:
- Publication type:
- Article
Joint reconstruction of Ictal/inter-ictal SPECT data for improved epileptic foci localization.
- Published in:
- Medical Physics, 2017, v. 44, n. 4, p. 1437, doi. 10.1002/mp.12167
- By:
- Publication type:
- Article